Brady Corporation demonstrates a compelling recovery trajectory with 13.8% year-over-year revenue growth in 2026Q3, supported by a fortress balance sheet with a negligible 0.07 debt-to-equity ratio.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 3, 2026 | $1.48+0.7% vs $1.47 | $437M+2.1% vs $428M |
Q2 2026 May 18, 2026 | $1.50+11.1% vs $1.35 | $435M+7.2% vs $406M |
Q1 2026 Feb 19, 2026 | $1.09+0.0% vs $1.09 | $384M+1.4% vs $379M |
Q4 2025 Nov 17, 2025 | $1.21+1.7% vs $1.19 | $405M+2.6% vs $395M |
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
Brady utilizes proprietary materials and high-margin consumables to sustain its industrial identification moat. Integration of the Honeywell PSS acquisition introduces significant debt and short-term execution risk.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
MILWAUKEE, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady”) announced today that it sold its Securimed SAS (“Securimed”) business for approximately EUR 53 million (approximately USD 59 million) to Safe Life International (“Safe Life”).
Benchmark BRC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Brady Corporation (BRC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $78.72 | $3.71B | 18.30 | 9.78% | 12.36% | 15.62% | 1.23% | |
| $97.83 | $3.81B | 21.71 | 10.33% | 5.62% | 13.23% | 0.2% | |
| $5.06 | $466.82M | 7.33 | -8.49% | 4.23% | 9.73% | 5.68% | |
| $19.33 | $603.14M | -20.70 | -16.6% | -2.65% | -5.81% | 5.45% | |
| $186.78 | $14.29B | 20.02 | 1.14% | 7.56% | 30.62% | 1.99% | |
| $29.58 | $40.51B | 12.90 | 6.4% | 11.37% | 23.89% | — |
Brady Corporation (BRC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Brady Corporation (BRC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 3, 2026·SEC
May 18, 2026·SEC
May 8, 2026·SEC
Get notified when BRC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Brady Corporation (BRC) stock FAQ — growth, dividends, profitability & financials explained
Brady Corporation (BRC) reported $1.66B in revenue in fiscal year 2026, which is also its trailing twelve months. That is 290% more than the $426.1M of fiscal year 1997.
Brady Corporation (BRC) grew revenue by 9.8% over the trailing twelve months, compared with the twelve months before.
Yes. Brady Corporation (BRC) earned $205.4M in net income over the trailing twelve months (a 12.4% net margin).
Yes. Brady Corporation (BRC) pays a dividend that yields 1.23% at the current price, a moderate yield.
Brady Corporation (BRC) had a return on equity (ROE) of 15.6% over the trailing twelve months. That is above the market's typical 10-15%.
Brady Corporation (BRC) generated $192.7M in free cash flow over the trailing twelve months.
